Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Albuquerque

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2019
Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trialAsal Rahimi, Osama Mohamad, Kevin Albuquerque, et al.
JAMA Network Open|August 15, 2025
Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral TherapyAlison K Yoder, Rehema J Thomas, Austin Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast IrradiationAsal Rahimi, Kimberly Thomas, Ann Spangler, et al.
American Journal of Clinical Oncology|February 23, 2017
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional StudyKevin Albuquerque, Michael Folkert, Jyoti Mayadev, et al.
Practical Radiation Oncology|November 18, 2024
Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast CancerAmbrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical TrialAsal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
Practical Radiation Oncology|October 24, 2023
Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice ReviewColton Ladbury, Mark H Sueyoshi, Nellie M Brovold, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
Oncoimmunology|June 15, 2018
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapyOsama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 6, 2019
Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trialAsal Rahimi, Osama Mohamad, Kevin Albuquerque, et al.
JAMA Network Open|August 15, 2025
Cervical Cancer Outcomes in Women With HIV in the Age of Antiretroviral TherapyAlison K Yoder, Rehema J Thomas, Austin Huang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 8, 2017
Preliminary Results of a Phase 1 Dose-Escalation Trial for Early-Stage Breast Cancer Using 5-Fraction Stereotactic Body Radiation Therapy for Partial-Breast IrradiationAsal Rahimi, Kimberly Thomas, Ann Spangler, et al.
American Journal of Clinical Oncology|February 23, 2017
Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional StudyKevin Albuquerque, Michael Folkert, Jyoti Mayadev, et al.
Practical Radiation Oncology|November 18, 2024
Financial Toxicity and Quality-of-Life Outcomes on a Phase 1 5-fraction Stereotactic Partial Breast Irradiation Protocol for Early-Stage Breast CancerAmbrosia Simmons, David Sher, Dr Dong Wook Nathan Kim, et al.
International Journal of Radiation Oncology, Biology, Physics|May 29, 2020
Risk Factors for Fat Necrosis After Stereotactic Partial Breast Irradiation for Early-Stage Breast Cancer in a Phase 1 Clinical TrialAsal Rahimi, Yuanyuan Zhang, Dong W Kim, et al.
Practical Radiation Oncology|October 24, 2023
Stereotactic Body Radiation Therapy for Gynecologic Malignancies: A Case-Based Radiosurgery Society Practice ReviewColton Ladbury, Mark H Sueyoshi, Nellie M Brovold, et al.
Practical Radiation Oncology|October 24, 2022
Radiation Therapy for Endometrial Cancer: An American Society for Radiation Oncology Clinical Practice GuidelineMatthew M Harkenrider, Nadeem Abu-Rustum, Kevin Albuquerque, et al.
Oncoimmunology|June 15, 2018
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapyOsama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, et al.
International Journal of Radiation Oncology, Biology, Physics|January 21, 2021
Cosmetic Outcomes of a Phase 1 Dose Escalation Study of 5-Fraction Stereotactic Partial Breast Irradiation for Early Stage Breast CancerAsal Rahimi, Howard E Morgan, Dong W Kim, et al.
Pageof 10